NeoGenomics is trading 5.91% lower at $18.00 following the October 5 announcement that Warren Stone will become CEO in January 2027.
- Shares fell 3.6% in after-hours trading after the announcement, despite preliminary Q3 revenue beating analysts’ expectations. NeoGenomics reiterated its existing full-year guidance rather than raising it immediately.
- Preliminary revenue was approximately $209 million, with NGS growth of 28% year over year. The broader market is higher and does not explain NeoGenomics’ drop.